Klingenstein Fields & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,705
| Closed | -$964K | – | 194 |
|
|
2019
Q3 | $964K | Sell |
9,705
-92,202
| -90% | -$8.76M | 0.05% | 114 |
|
|
2019
Q2 | $9.42M | Buy |
101,907
+92
| +0.1% | +$8.74K | 0.49% | 63 |
|
|
2019
Q1 | $9.61M | Sell |
101,815
-41,440
| -29% | -$3.62M | 0.52% | 65 |
|
|
2018
Q4 | $9.18M | Sell |
143,255
-30,228
| -17% | -$2.23M | 0.39% | 65 |
|
|
2018
Q3 | $15.5M | Sell |
173,483
-13,319
| -7% | -$1.18M | 0.56% | 54 |
|
|
2018
Q2 | $14.8M | Buy |
186,802
+17,228
| +10% | +$1.43M | 0.57% | 55 |
|
|
2018
Q1 | $15.1M | Buy |
169,574
+27,243
| +19% | +$2.62M | 0.58% | 52 |
|
|
2017
Q4 | $14.9M | Sell |
142,331
-31,767
| -18% | -$3.58M | 0.55% | 54 |
|
|
2017
Q3 | $25.4M | Sell |
174,098
-6,565
| -4% | -$894K | 0.98% | 41 |
|
|
2017
Q2 | $23.5M | Buy |
180,663
+12,166
| +7% | +$1.49M | 0.92% | 42 |
|
|
2017
Q1 | $21M | Buy |
168,497
+19,685
| +13% | +$2.36M | 0.85% | 43 |
|
|
2016
Q4 | $17.2M | Buy |
148,812
+4,451
| +3% | +$496K | 0.75% | 47 |
|
|
2016
Q3 | $15.1M | Buy |
144,361
+859
| +0.6% | +$93K | 0.69% | 47 |
|
|
2016
Q2 | $14.2M | Buy |
143,502
+6,864
| +5% | +$710K | 0.66% | 45 |
|
|
2016
Q1 | $13.7M | Sell |
136,638
-16,447
| -11% | -$1.69M | 0.68% | 47 |
|
|
2015
Q4 | $18.3M | Buy |
153,085
+7,287
| +5% | +$843K | 0.91% | 39 |
|
|
2015
Q3 | $15.8M | Buy |
145,798
+135,638
| +1,335% | +$16.8M | 0.78% | 47 |
|
|
2015
Q2 | $1.18M | Sell |
10,160
-200
| -2% | -$22.9K | 0.05% | 120 |
|
|
2015
Q1 | $1.19M | Sell |
10,360
-370
| -3% | -$44.2K | 0.05% | 122 |
|
|
2014
Q4 | $1.2M | Sell |
10,730
-4,300
| -29% | -$453K | 0.05% | 116 |
|
|
2014
Q3 | $1.43M | Sell |
15,030
-300
| -2% | -$27.1K | 0.06% | 116 |
|
|
2014
Q2 | $1.32M | Sell |
15,330
-2,470
| -14% | -$188K | 0.06% | 123 |
|
|
2014
Q1 | $1.24M | Sell |
17,800
-83,520
| -82% | -$6.61M | 0.06% | 122 |
|
|
2013
Q4 | $8.56M | Sell |
101,320
-6,670
| -6% | -$528K | 0.31% | 72 |
|
|
2013
Q3 | $8.32M | Sell |
107,990
-205,470
| -66% | -$14.4M | 0.33% | 70 |
|
|
2013
Q2 | $18.3M | Buy |
+313,460
| New | +$18.9M | 0.66% | 43 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Klingenstein Fields & Co's CELG Position: Q4 2019 in Review
Klingenstein Fields & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,705 shares — an estimated $964K sold.
Klingenstein Fields & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $25.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Klingenstein Fields & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Klingenstein Fields & Co sold 9,705 Celgene Corp shares in Q4 2019, an estimated $964K.
- Klingenstein Fields & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Klingenstein Fields & Co's Celgene Corp position peaked at $25.4M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Klingenstein Fields & Co's 13F filing for Q4 2019, filed 4 Feb 2020.